Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Cash & Equivalents: 2021-2025

Historic Cash & Equivalents for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $203.9 million.

  • LifeStance Health's Cash & Equivalents rose 9870.68% to $203.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $203.9 million, marking a year-over-year increase of 9870.68%. This contributed to the annual value of $154.6 million for FY2024, which is 9609.64% up from last year.
  • As of Q3 2025, LifeStance Health's Cash & Equivalents stood at $203.9 million, which was up 9870.68% from $188.9 million recorded in Q2 2025.
  • LifeStance Health's Cash & Equivalents' 5-year high stood at $276.2 million during Q2 2021, with a 5-year trough of $42.6 million in Q3 2023.
  • Its 5-year average for Cash & Equivalents is $124.2 million, with a median of $105.6 million in 2022.
  • In the last 5 years, LifeStance Health's Cash & Equivalents plummeted by 6499.26% in 2022 and then surged by 17165.48% in 2025.
  • Over the past 5 years, LifeStance Health's Cash & Equivalents (Quarter) stood at $148.0 million in 2021, then fell by 26.62% to $108.6 million in 2022, then dropped by 27.43% to $78.8 million in 2023, then skyrocketed by 96.1% to $154.6 million in 2024, then soared by 31.92% to $203.9 million in 2025.
  • Its last three reported values are $203.9 million in Q3 2025, $188.9 million for Q2 2025, and $134.3 million during Q1 2025.